The DOI matches its OpenAlex record; 55 of the 55 references it cites were found in a registry or an index.
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Open accessAbstract
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by pathogenic autoantibodies against nucleoproteins and DNA. Here we show that DNA-containing immune complexes (ICs) within lupus serum (SLE-ICs), but not protein-containing ICs from other autoimmune rheumatic diseases, stimulates plasmacytoid DCs (PDCs) to produce cytokines and chemokines via a cooperative interaction between Toll-like receptor 9 (TLR9) and FcgammaRIIa (CD32). SLE-ICs transiently colocalized to a subcellular compartment containing CD32 and TLR9, and CD32+, but not CD32-, PDCs internalized and responded to SLE-ICs. Our findings demonstrate a novel functional interaction between Fc receptors and TLRs, defining a pathway in which CD32 delivers SLE-ICs to intracellular lysosomes containing TLR9, inducing a signaling cascade leading to PDC activation. These data demonstrate that endogenous DNA-containing autoantibody complexes found in the serum of patients with SLE activate the innate immune system and suggest a novel mechanism whereby these ICs contribute to the pathogenesis of this autoimmune disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 15×
“Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.”
BackgroundInfluentialToll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,601
Self-citationToll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964 · cited 1×
“TLR9 is functionally expressed on mouse but not human mDCs, a difference which might render mouse models of SLE less directly relevant to human SLE (45).”
BackgroundHornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., & Golenbock, D. T. (2004) · Nature Immunology · doi:10.1038/ni1028 · Cited by 1,361
Self-citationRenal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
Maziad, A. S. A., Torrealba, J., Seikaly, M. G., Hassler, J. R., & Hendricks, A. R. (2017) · Case Reports in Nephrology and Dialysis · doi:10.1159/000475493 · Cited by 1,299
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J., Sato, A., Akira, S., Medzhitov, R., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,198
Number of CpG islands and genes in human and mouse.
Antequera, F., & Bird, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11995 · Cited by 996
Pathogenesis of systemic lupus erythematosus
Mok, C. C., & Lau, C. S. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.7.481 · Cited by 942
Toll-like receptors stimulate human neutrophil function
Hayashi, F., Means, T. K., & Luster, A. D. (2003) · Blood · doi:10.1182/blood-2003-04-1078 · Cited by 939
Self-citationKrug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3026::aid-immu3026>3.0.co;2-h · Cited by 786
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., & Colonna, M. (2004) · Blood · doi:10.1182/blood-2003-08-2674 · Cited by 695
Toll-like receptors: key mediators of microbe detection
Underhill, D. M., & Ozinsky, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00304-1 · Cited by 681
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240303 · Cited by 677
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572 · cited 1×
“These autoantibodies are thought to contribute directly to the pathogenesis of SLE, as they precede the development of clinical disease in most patients, and levels of anti-DNA antibodies correlate with disease activity (4, 5).”
BackgroundAarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
Activation of Autoreactive B Cells by CpG dsDNA
Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J., & Marshak-Rothstein, A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00323-6 · Cited by 521
Boulé, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 518
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
Santiago-Raber, M.-L., Baccala, R., Haraldsson, K. M., Choubey, D., Stewart, T. A., Kono, D. H., & Theofilopoulos, A. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021996 · Cited by 509
Latz, E., Visintin, A., Lien, E., Fitzgerald, K. A., Monks, B. G., Kurt-Jones, E. A., Golenbock, D. T., & Espevik, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207873200 · Cited by 449
Self-citationMeans, T. K., Hayashi, F., Smith, K. D., Aderem, A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 410
Self-citationBåve, U., Magnusson, M., Eloranta, M.-L., Perers, A., Alm, G. V., & Rönnblom, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3296 · Cited by 380
DIVERGENT ROLES FOR F c RECEPTORS AND COMPLEMENT IN VIVO
Ravetch, J. V., & Clynes, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.421 · Cited by 366
RÖNNBLOM, L. E., ALM, G. V., & ÖBERG, K. E. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00144.x · Cited by 360
Tesch, G. H., Maifert, S., Schwarting, A., Rollins, B. J., & Kelley, V. R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1813 · Cited by 303
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Rönnblom, L., & Alm, G. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.f59 · Cited by 288
Vallin, H., Perers, A., ALM, G. V., & Rönnblom, L. (1999) · PubMed · Cited by 284
Vallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6306 · Cited by 256
VALLIN, H., BLOMBERG, S., ALM, G. V., CEDERBLAD, B., & RÖNNBLOM, L. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00772.x · Cited by 252
Bird, A. P., Taggart, M. H., Nicholls, R. D., & Higgs, D. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04851.x · Cited by 201
The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-α Inducer
Båve, U., Alm, G. V., & Rönnblom, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3519 · Cited by 167
Systemic lupus erythematosus and the type I interferon system.
Rönnblom, L., & Alm, G. V. (2003) · Arthritis Research · doi:10.1186/ar625 · Cited by 158
Structure and function of Toll-like receptor proteins
Means, T. K., Golenbock, D. T., & Fenton, M. J. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00939-5 · Cited by 132
Self-citationRönnelid, J., Tejde, A., Mathsson, L., Nilsson-Ekdahl, K., & Nilsson, B. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.1.37 · Cited by 130
SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS
Narumi, S., Takeuchi, T., Kobayashi, Y., & Konishi, K. (2000) · Cytokine · doi:10.1006/cyto.2000.0757 · Cited by 126
The natural interferon-α producing cells in systemic lupus erythematosus
Rönnblom, L., & Alm, G. V. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00757-7 · Cited by 112
Lenert, P. S., Stunz, L. L., Yi, A., Krieg, A. Μ., & Ashman, R. F. (2001) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729001317022241 · Cited by 109
Båve, U., Vallin, H., Alm, G. V., & Rönnblom, L. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0519 · Cited by 104
Toll-like receptors: mammalian 'taste receptors' for a smorgasbord of microbial invaders
Sieling, P. A., & Modlin, R. L. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00288-6 · Cited by 86
Binding Properties of Human Anti‐DNA Antibodies to Cloned Human DNA Fragments
Sano, H., TAKAI, O., Harata, N. C., YOSHINAGA, K., KODAMA‐KAMADA, I., & Sasaki, T. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb01188.x · Cited by 64
Sato, Y., Miyata, M., Sato, Y., Nishimaki, T., Kochi, H., & Kasukawa, R. (1999) · PubMed · Cited by 57
Bootsma, H., Spronk, P. E., Hummel, E. J., de Boer, G., ter Borg, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609065646 · Cited by 32
Lawrence (1998) · doi:10.1002/1529-0131(199805)41:5<778::aid-art4>3.0.co;2-v
Cited by
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,736
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910
Metadata
- Authors
- Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2005-01-20
- Volume
- 115
- Issue
- 2
- Pages
- 407-417
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2137540618
- Cited by
- 849
- References
- 55
- FWCI
- 39.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.